{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:08:23Z","timestamp":1785708503876,"version":"3.56.0"},"reference-count":30,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.3233\/jnd-190453","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T11:46:04Z","timestamp":1587728764000},"page":"257-268","source":"Crossref","is-referenced-by-count":59,"title":["Prospective Cohort Study of Nusinersen Treatment in Adults with Spinal Muscular Atrophy"],"prefix":"10.1177","volume":"7","author":[{"given":"Crystal Jing Jing","family":"Yeo","sequence":"first","affiliation":[{"name":"Center for Genomic Medicine and Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Institute of Molecular and Cell Biology, Experimental Drug Development Center and National Neuroscience Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Simeone","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine and Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise L.","family":"Townsend","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine and Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Physical Therapy, School of Health and Rehabilitation Sciences, MGH Institute of Health Professions, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine and Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine and Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"8","key":"10.3233\/JND-190453_ref1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: A timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Archives of neurology"},{"issue":"3","key":"10.3233\/JND-190453_ref2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.3233\/JND-190453_ref3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-190453_ref4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1101\/gad.256644.114","article-title":"Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models","volume":"29","author":"Hua","year":"2015","journal-title":"Genes & development"},{"issue":"18","key":"10.3233\/JND-190453_ref5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.3233\/JND-190453_ref6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.3233\/JND-190453_ref7","doi-asserted-by":"crossref","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PloS One"},{"issue":"6","key":"10.3233\/JND-190453_ref8","doi-asserted-by":"crossref","first-page":"e0199657","DOI":"10.1371\/journal.pone.0199657","article-title":"Ambulatory function in spinal muscular atrophy: Age-related patterns of progression","volume":"13","author":"Montes","year":"2018","journal-title":"PloS one"},{"issue":"5","key":"10.3233\/JND-190453_ref9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Annals of neurology"},{"issue":"3","key":"10.3233\/JND-190453_ref10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/ene.13534","article-title":"Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c\u20134","volume":"25","author":"Wadman","year":"2018","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.3233\/JND-190453_ref11","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","article-title":"Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy","volume":"93","author":"Wijngaarde","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JND-190453_ref12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mus.25120","article-title":"Six-minute walk test is reliable and valid in spinal muscular atrophy","volume":"54","author":"Dunaway Young","year":"2016","journal-title":"Muscle & Nerve"},{"issue":"15 Supplement","key":"10.3233\/JND-190453_ref13","doi-asserted-by":"crossref","first-page":"P4.452","DOI":"10.1212\/WNL.90.15_supplement.P4.452","article-title":"Reliability of Spinal Muscular Atrophy Functional Rating Scale (SMAFRS) in Ambulatory Adults with Spinal Muscular Atrophy. (P4.452)","volume":"90","author":"Elsheikh","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JND-190453_ref14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.25430","article-title":"Revised upper limb module for spinal muscular atrophy: Development of a new module","volume":"55","author":"Mazzone","year":"2017","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.3233\/JND-190453_ref15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0883073809332702","article-title":"Clinical outcome measures in spinal muscular atrophy","volume":"24","author":"Montes","year":"2009","journal-title":"J Child Neurol"},{"issue":"1","key":"10.3233\/JND-190453_ref16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12883-017-0790-9","article-title":"Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy","volume":"17","author":"Pera","year":"2017","journal-title":"BMC Neurology"},{"issue":"21","key":"10.3233\/JND-190453_ref17","first-page":"e2492","article-title":"Nusinersen in later-onset spinal muscular atrophy","volume":"92","author":"Darras","year":"2019","journal-title":"Long-term results from the phase 1\/2 studies"},{"issue":"12","key":"10.3233\/JND-190453_ref18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III","volume":"26","author":"Glanzman","year":"2011","journal-title":"J Child Neurol"},{"issue":"2","key":"10.3233\/JND-190453_ref19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","article-title":"Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials","volume":"26","author":"Mercuri","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.3233\/JND-190453_ref20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.26419","article-title":"Revised upper limb module for spinal muscular atrophy: 12 month changes","volume":"59","author":"Pera","year":"2019","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.3233\/JND-190453_ref21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nmd.2014.11.008","article-title":"Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes","volume":"25","author":"Sivo","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.3233\/JND-190453_ref22","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: A prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"Kissel","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/JND-190453_ref23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/archdischild-2014-307396","article-title":"Timed motor function tests capacity in healthy children","volume":"101","author":"Pereira","year":"2016","journal-title":"Archives of Disease in Childhood"},{"issue":"12","key":"10.3233\/JND-190453_ref24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nmd.2009.09.009","article-title":"The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module","volume":"19","author":"Iannaccone","year":"2009","journal-title":"Neuromuscular disorders: NMD"},{"issue":"1","key":"10.3233\/JND-190453_ref25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11136-007-9282-5","article-title":"The PedsQL\u2122 Multidimensional Fatigue Scale in young adults: Feasibility, reliability and validity in a University student population","volume":"17","author":"Varni","year":"2008","journal-title":"Quality of Life Research"},{"issue":"2","key":"10.3233\/JND-190453_ref26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.3233\/JND-190453_ref27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/mus.26794","article-title":"Limitations of 6-minute walk test reference values for spinal muscular atrophy","volume":"61","author":"Goodwin","year":"2020","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.3233\/JND-190453_ref28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mus.26769","article-title":"Nusinersen for olderpatients with spinal muscular atrophy: A real-world clinical setting experience","volume":"61","author":"Veerapandiyan","year":"2020","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.3233\/JND-190453_ref29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JND-190416","article-title":"Safety and TreatmentEffects of Nusinersen in Longstanding Adult 5q-SMA Type 3-A Prospective Observational Study","volume":"6","author":"Walter","year":"2019","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"6","key":"10.3233\/JND-190453_ref30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00063198-200011000-00004","article-title":"Complications and consequences of obstructive sleep apnea","volume":"6","author":"Harding","year":"2000","journal-title":"Current Opinion in Pulmonary Medicine"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-190453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:27Z","timestamp":1777506567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-190453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jnd-190453","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}